Our study is also the first to identify CXCR6+ T-cell subsets as being enriched in glioblastoma, as well as demonstrating CXCL16 expression in dissociated tumour biopsies and glioblastoma cell-lines. The gene discussed is CXCR6; the disease is neoplasm.